Stability of Hydrocortisone Sodium Succinate in Intensive Care Units: Focus on Practical Points

dc.contributor.authorLeanpolchareanchai J.
dc.contributor.authorDilokpattanamongkol P.
dc.contributor.authorLertwattanachai T.
dc.contributor.authorTrisataya A.
dc.contributor.authorWongrakpanich A.
dc.contributor.authorPravitharangul T.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T17:52:28Z
dc.date.available2023-06-18T17:52:28Z
dc.date.issued2022-04-01
dc.description.abstractBackground: Although single daily 24 hours preparation of hydrocortisone solution infusion is widely used in intensive care clinical practice, most manufacturers limit its infusion time to only four hours. The data on efficacy of this practice are scarce. Objective: To determine the physical and chemical stability of hydrocortisone solution used in intensive care units (ICU). Materials and Methods: Powder form of 100 mg hydrocortisone was reconstituted first with sterile water for injection (SWI) and then added to normal saline solution (NSS) to obtain 1 and 2 mg/mL solutions, or first reconstituted with NSS then added to bag of NSS to obtain 1 mg/mL solution. The solutions were then stored in three different conditions, refrigerator (4±2?), ICU (25±3°), and hospital room (30±2°) temperatures for 48 hours. The physical and chemical stabilities were assessed at an initial time, 4, 8, 12, 24, and 48 hours. Results: Hydrocortisone reconstituted in SWI showed an acceptable labeled amount range (100.28±3.83%), similar to reconstitution in NSS (96.05±1.00%). Hydrocortisone solutions of 1 and 2 mg/mL stored at 4±2?, 25±3°, and 30±2° showed similar percent label amount, and the statistical tests were not significantly different among the three ranges of temperatures (p>0.05). Conclusion: Hydrocortisone reconstituted using SWI followed by NSS to obtain final concentrations of 1 to 2 mg/mL or using only NSS to obtain a final concentration of 1 mg/mL, provided an acceptable range of % hydrocortisone remaining up to 48 hours when stored at 4±2?, 25±3?, and 30±2?.
dc.identifier.citationJournal of the Medical Association of Thailand Vol.105 No.4 (2022)
dc.identifier.doi10.35755/jmedassocthai.2022.04.13293
dc.identifier.issn01252208
dc.identifier.scopus2-s2.0-85128484137
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/85978
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleStability of Hydrocortisone Sodium Succinate in Intensive Care Units: Focus on Practical Points
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85128484137&origin=inward
oaire.citation.issue4
oaire.citation.titleJournal of the Medical Association of Thailand
oaire.citation.volume105
oairecerif.author.affiliationRamathibodi Hospital
oairecerif.author.affiliationVajira Hospital
oairecerif.author.affiliationMahidol University

Files

Collections